Market revenue in 2024 | USD 215.5 million |
Market revenue in 2030 | USD 283.5 million |
Growth rate | 4.7% (CAGR from 2024 to 2030) |
Largest segment | Consumables |
Fastest growing segment | Rapid Testing Devices |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments, Rapid Testing Devices, Services |
Key market players worldwide | Quest Diagnostics Inc, Abbott Laboratories, QuidelOrtho Corp, Roche Holding AG ADR, Thermo Fisher Scientific Inc, Siemens Healthineers AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Labcorp Holdings Inc, Clinical Reference Laboratory, Cordant Health Solutions, Legacy Medical, Draegerwerk AG & Co KGaA, Omega Laboratories |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug testing market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 34.62% in 2024. Horizon Databook has segmented the Italy drug testing market based on consumables, instruments, rapid testing devices, services covering the revenue growth of each sub-segment from 2018 to 2030.
The growth of Italy drug testing market can primarily be attributed to strict implementation of workplace regulations to avoid accidents, growing awareness of substance abuse & associated disorders, stringent government regulations, and technological advancements in testing technologies.
In addition, increasing implementation of strategies such as joint ventures, collaborations, and acquisitions is projected to have a positive impact on the market. For instance, in August 2022, DIESSE Diagnostica Senese announced a strategic collaboration with Grifols for the distribution of Grifols' Promonitor assays portfolio in Italy.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy drug testing market , including forecasts for subscribers. This country databook contains high-level insights into Italy drug testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account